GSK3β Inhibits Cardiac Hypertrophy through FoxO1, but Protects the Heart from Dysfunction Independently of FoxO1 under Pressure Overload

被引：0
|
作者：
Maejima, Yasuhiro [1 ]
Zhai, Peiyong [1 ]
Sadoshima, Junichi [1 ]
机构：
[1] UMDNJ New jersey Med Sch, Newark, NJ USA
来源：
CIRCULATION | 2010年 / 122卷 / 21期
关键词：
Cardiac hypertrophy; Heart failure; Molecular biology; Experimental heart failure; Transgenic models;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A18263
引用
收藏
页数：2
相关论文
共 50 条
  • [1] GSK3βAlleviates Cardiac Hypertrophy and LV Dysfunction Through Modulation of FoxO1 Transcriptional Activity in Response to Pressure Overload
    Maejima, Yasuhiro
    Isobe, Mitsuaki
    Sadoshima, Junichi
    [J]. JOURNAL OF CARDIAC FAILURE, 2016, 22 (09) : S206 - S206
  • [2] GSK-3β Prevents Cardiac Dysfunction through Modulation of FoxO1 Activity Under Pressure Overload
    Maejima, Yasuhiro
    Zhai, Peiyong
    Sadoshima, Junichi
    [J]. CIRCULATION, 2011, 124 (21)
  • [3] GSK-3β Mitigates Cardiac Hypertrophy by Phosphorylating Foxo1 During Pressure Overload
    Maejima, Yasuhiro
    Nagarajan, Narayani
    Zhai, Peiyong
    Isobe, Mitsuaki
    Sadoshima, Junichi
    [J]. CIRCULATION, 2016, 134
  • [4] FoxO1 Attenuates Physiological Cardiac Hypertrophy
    Schugar, Rebecca C.
    Muslin, Anthony J.
    [J]. CIRCULATION, 2010, 122 (21)
  • [5] GSK3β regulates gluconeogenic gene expression through HNF4α and FOXO1
    Sakamaki, Jun-ichi
    Daitoku, Hiroaki
    Kaneko, Yuta
    Hagiwara, Ayano
    Ueno, Katsuya
    Fukamizu, Akiyoshi
    [J]. JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2012, 32 (02) : 96 - 101
  • [6] The role and molecular mechanism of FoxO1 in mediating cardiac hypertrophy
    Yu, Wei
    Chen, Chunjuan
    Cheng, Jidong
    [J]. ESC HEART FAILURE, 2020, 7 (06): : 3497 - 3504
  • [7] Loss of microRNA-27a induces cardiac dysfunction through activating FoxO1
    Qin, X-D
    Liu, L.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (13) : 5941 - 5948
  • [8] Akt signalling through GSK-3β, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy
    Leger, Bertrand
    Cartoni, Romain
    Praz, Manu
    Lamon, Severine
    Deriaz, Olivier
    Crettenand, Antoinette
    Gobelet, Charles
    Rohmer, Paul
    Konzelmann, Michel
    Luthi, Francois
    Russell, Aaron P.
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 2006, 576 (03): : 923 - 933
  • [9] Glucagon receptor blockage inhibits ?-cell dedifferentiation through FoxO1
    Wang, Kangli
    Cui, Xiaona
    Li, Fei
    Xia, Li
    Wei, Tianjiao
    Liu, Junling
    Fu, Wei
    Yang, Jin
    Hong, Tianpei
    Wei, Rui
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2022, 324 (01): : E97 - E113
  • [10] Klotho protects chondrocyte viability via FOXO1/3 in osteoarthritis
    Wei, Wei
    Ji, Liefeng
    Duan, Wanli
    Zhu, Jiang
    [J]. TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2021, 20 (09) : 1961 - 1968
12345